PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.68%
Revenue growth above 1.5x STERV.HE's 1.24%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-2.93%
Negative gross profit growth while STERV.HE is at 0.50%. Joel Greenblatt would examine cost competitiveness or demand decline.
3.76%
EBIT growth 50-75% of STERV.HE's 6.22%. Martin Whitman would suspect suboptimal resource allocation.
3.76%
Operating income growth at 50-75% of STERV.HE's 6.22%. Martin Whitman would doubt the firm’s ability to compete efficiently.
2.34%
Net income growth under 50% of STERV.HE's 28.07%. Michael Burry would suspect the firm is falling well behind a key competitor.
-10.00%
Negative EPS growth while STERV.HE is at 35.71%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-10.00%
Negative diluted EPS growth while STERV.HE is at 35.71%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
13.71%
Share change of 13.71% while STERV.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
13.71%
Slight or no buyback while STERV.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
44.92%
OCF growth under 50% of STERV.HE's 240.96%. Michael Burry might suspect questionable revenue recognition or rising costs.
241.10%
FCF growth 50-75% of STERV.HE's 398.08%. Martin Whitman would see if structural disadvantages exist in generating free cash.
-30.92%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-23.62%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-14.59%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
258.09%
10Y OCF/share CAGR above 1.5x STERV.HE's 6.18%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
197.48%
5Y OCF/share CAGR above 1.5x STERV.HE's 39.00%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-63.92%
Negative 3Y OCF/share CAGR while STERV.HE stands at 4.43%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
131.40%
Net income/share CAGR above 1.5x STERV.HE's 3.33% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-78.98%
Negative 5Y net income/share CAGR while STERV.HE is 124.62%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
85.36%
Below 50% of STERV.HE's 14500.00%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
13.66%
5Y equity/share CAGR above 1.5x STERV.HE's 0.92%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
16.47%
3Y equity/share CAGR above 1.5x STERV.HE's 10.19%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
103.59%
3Y dividend/share CAGR above 1.5x STERV.HE's 23.21%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
9.45%
AR growth well above STERV.HE's 2.18%. Michael Burry fears inflated revenue or higher default risk in the near future.
-5.88%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.86%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-7.18%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-3.10%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
9.07%
SG&A growth of 9.07% while STERV.HE is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.